Safety and Pharmacodynamic Study of Sobetirome in X-Linked Adrenoleukodystrophy (X-ALD)
NCT01787578
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
revisions to original study protocol underway
Conditions
X-Linked Adrenoleukodystrophy
Adrenomyeloneuropathy
Interventions
DRUG:
Sobetirome
Sponsor
Thomas S. Scanlan